Eli Lilly (LLY) Stock Analysis
HealthcarePharmaceutical Preparations
We use a few cookies
Finrys uses only the cookies needed to sign you in and remember your preferences. No analytics or tracking.
The company grew at 29.26% annually in the past. To stay cautious, the baseline is capped at 15% — such fast growth may not last and the business can slow down over time.